Paperpal Prime Logo

Regenerative Medicine : Impact Factor & More

eISSN: 1746-076XpISSN: 1746-0751

Key Metrics

CiteScore
4.5
Eigenfactor
0.001 - 0.005
H-Index
72
Impact Factor
< 5
SJR
Q2Embryology
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Regenerative Medicine

Regenerative Medicine Journal Specifications

Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Regenerative Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Regenerative Medicine

Engineering stem cell-derived islets for type 1 diabetes: genetic strategies for immune evasion and stress resilience.
  • 21 Oct 2026
  • Regenerative medicine
Industry updates in advanced therapy medicinal products and regenerative medicine - August 2026.
  • 11 Sep 2026
  • Regenerative medicine
Clinical manufacturing of adipose-derived stem cells for therapeutic use: current technologies, quality systems and production challenges
  • 2 Sep 2026
  • Regenerative Medicine
Extracorporeal shockwave therapy in musculoskeletal conditions: a narrative review.
  • 2 Sep 2026
  • Regenerative medicine
Early economic evaluation of tissue engineered vascular access grafts for hemodialysis
  • 2 Sep 2026
  • Regenerative Medicine
From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.
  • 2 Sep 2026
  • Regenerative medicine
Engineering stem cell-derived islets for type 1 diabetes: genetic strategies for immune evasion and stress resilience.
  • 21 Oct 2026
  • Regenerative medicine
Industry updates in advanced therapy medicinal products and regenerative medicine - August 2026.
  • 11 Sep 2026
  • Regenerative medicine
Clinical manufacturing of adipose-derived stem cells for therapeutic use: current technologies, quality systems and production challenges
  • 2 Sep 2026
  • Regenerative Medicine
Extracorporeal shockwave therapy in musculoskeletal conditions: a narrative review.
  • 2 Sep 2026
  • Regenerative medicine
Early economic evaluation of tissue engineered vascular access grafts for hemodialysis
  • 2 Sep 2026
  • Regenerative Medicine
From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.
  • 2 Sep 2026
  • Regenerative medicine

FAQs on Regenerative Medicine